These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1191553)

  • 1. Coagulation in an agarose gel and its application to the detection and measurement of factor VIII antibodies.
    Bird P
    Br J Haematol; 1975 Feb; 29(2):329-40. PubMed ID: 1191553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter: Detection and measurement of factor VIII antibodies in an agarose gel: a modified method.
    Rainsford SG; Hall A
    Br J Haematol; 1976 Jun; 33(2):309. PubMed ID: 1268100
    [No Abstract]   [Full Text] [Related]  

  • 3. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel.
    Jorquera JI; Carmona E; Aznar JA; Peiró A; Sánchez-Cuenca JM
    Thromb Haemost; 1985 Aug; 54(2):377-80. PubMed ID: 3936211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for detecting factor-VIII clotting activity associated with factor VIII-related antigen in agarose gels.
    Bird P; Rizza CR
    Br J Haematol; 1975 Sep; 31(1):5-12. PubMed ID: 1240008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the agarose gel method to identify and quantitate factor VIII:C inhibitors.
    Cassidy PG; Triplett DA; LaDuca FM
    Am J Clin Pathol; 1985 Jun; 83(6):697-706. PubMed ID: 3923823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of the plasma-agarose gel diffusion method to the detection and measurement of anti-Factor-VIII:C and other inhibitors of coagulation].
    Jorquera JI; Carmona E; Aznar JA; Cañada M; Peiró A; Sánchez-Cuenca JM
    Sangre (Barc); 1985; 30(4-A):411-6. PubMed ID: 2416066
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays.
    Bowyer A; Kitchen S; Maclean R
    Int J Lab Hematol; 2021 Aug; 43(4):O204-O206. PubMed ID: 33764652
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of low molecular weight factor VIII by affinity chromatography using factor VIII - sepharose.
    Horowitz B; Lippin A; Woods KR
    Thromb Res; 1979; 14(2-3):463-75. PubMed ID: 442017
    [No Abstract]   [Full Text] [Related]  

  • 9. Assay challenges (and opportunities) with non-factor VIII therapies for Hemophilia A.
    Aleman MM; Leksa NC; Peters R; Salas J
    Expert Rev Mol Diagn; 2019 Jan; 19(1):1-3. PubMed ID: 30513018
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasma.
    Weinstein M; Chute L; Deykin D
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5137-41. PubMed ID: 6795628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays.
    Hornsey VS; Waterston YG; Prowse CV
    J Clin Pathol; 1988 May; 41(5):562-7. PubMed ID: 3133400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.
    Allain JP; Frommel D
    Blood; 1974 Sep; 44(3):313-22. PubMed ID: 4604102
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies.
    Takase T; Rotblat F; Goodall AH; Kernoff PB; Middleton S; Chand S; Denson KW; Austen DE; Tuddenham EG
    Br J Haematol; 1987 Aug; 66(4):497-502. PubMed ID: 3117089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the Bethesda and New Oxford methods of factor VIII antibody assay.
    Austen DE; Lechner K; Rizza CR; Rhymes IL
    Thromb Haemost; 1982 Feb; 47(1):72-5. PubMed ID: 6803384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E; Collecutt M; Street A
    Methods Mol Biol; 2013; 992():321-33. PubMed ID: 23546724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
    Parry DH; Bloom AL
    J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
    Allain JP; Gaillandre A; Lee H
    J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular structural studies of human factor VIII.
    McKee PA; Andersen JC; Switzer ME
    Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP; Gaillandre A; Frommel D
    Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma.
    Regnault V; Rivat C; Vallet JP; Francois-Gerard C; Brochier G; Allain JP
    Thromb Res; 1987 Jan; 45(1):51-7. PubMed ID: 3105113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.